Global Companion Animal Cardiac Drugs Market Size & Outlook
Global companion animal cardiac drugs market, 2021-2033 (US$M)
Global companion animal cardiac drugs market highlights
- The global companion animal cardiac drugs market generated a revenue of USD 1,880.7 million in 2024 and is expected to reach USD 3,732.5 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 8.1% by 2033.
- In terms of segment, dogs accounted for a revenue of USD 1,997.1 million in 2024.
- Dogs is the most lucrative animal type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
Global data book summary
| Market revenue in 2024 | USD 1,880.7 million |
| Market revenue in 2033 | USD 3,732.5 million |
| Growth rate | 8.1% (CAGR from 2025 to 2033) |
| Largest segment | Dogs |
| Fastest growing segment | Dogs |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dogs |
Other key industry trends
- In terms of revenue, the North America accounted for 38.0% of the global companion animal cardiac drugs market in 2024.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Companion Animal Cardiac Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bimeda | View profile | 1001-5000 | Dublin, Dublin, Ireland, Europe | https://www.bimeda.com/ |
| Biogenesis Bago | View profile | 501-1000 | Garín, Buenos Aires, Argentina, South America | https://www.biogenesisbago.com/en/ |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | http://www.dechra.com |
| Vetoquinol SA | View profile | 2483 | Magny-Vernois, BP 189, Lure cedex, France, 70204 | http://www.vetoquinol.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Elanco Animal Health Inc | View profile | 9800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | https://www.elanco.com |
| CEVA Inc | View profile | 424 | 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 | https://www.ceva-dsp.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global companion animal cardiac drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal cardiac drugs market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 106.19% in 2024. Horizon Databook has segmented the Global companion animal cardiac drugs market based on dogs covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Companion Animal Cardiac Drugs Animal Type Outlook (Revenue, USD Million, 2021-2033)
- Dogs
- Cats
- Horses
- Others
- Global Companion Animal Cardiac Drugs Product Outlook (Revenue, USD Million, 2021-2033)
- Pimobendan
- Spironolactone and Benazepril Hydrochloride
- Furosemide
- Others
- Global Companion Animal Cardiac Drugs Indication Outlook (Revenue, USD Million, 2021-2033)
- Congestive Heart Failure
- Myocardial (Heart Muscle) Disease
- Arrhythmias
- Others
- Global Companion Animal Cardiac Drugs End Use Outlook (Revenue, USD Million, 2021-2033)
- Veterinary Hospitals & Clinics
- Others
- Global Companion Animal Cardiac Drugs Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital/ Clinic Pharmacy
- Retail
- E-Commerce
Reasons to subscribe to Global companion animal cardiac drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global companion animal cardiac drugs market databook
-
Our clientele includes a mix of companion animal cardiac drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global companion animal cardiac drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global companion animal cardiac drugs market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global companion animal cardiac drugs market size, by regions, 2021-2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
